MRK’s head of R&D, Peter Kim, just talked up Boceprevir and said absolutely nothing about MK-7009. The demise (or divestment) of MK-7009 is a fait accompli, IMO.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”